戻る
CARsgen Therapeutics Holdings Limited (02171.HK)価格
02171.HK 株価推移チャート
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$16.19
-1.22%
$-0.19
休場: Jan 16, 16:00:00 HKT
データなしEarnings FAQ
02171.HKの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
CARsgen Therapeutics Holdings Limited 02171.HKの前四半期の収益はどうでしたか？
CARsgen Therapeutics Holdings Limitedの収益見積もりはいくらですか？
CARsgen Therapeutics Holdings Limitedの収益品質スコアはどれくらいですか？
CARsgen Therapeutics Holdings Limitedはいつ収益を報告しますか？
CARsgen Therapeutics Holdings Limitedの予想収益はいくらですか？
CARsgen Therapeutics Holdings Limitedは収益予想を上回りましたか？
主要データ
前終値
$16.39
始値
$16.39
当日レンジ
$15.87 - $16.6
52週レンジ
$8.5 - $25.6
取引高
1.3M
平均取引高
1.7M
1株当たり利益(TTM)
-1.06
配当利回り
--
時価総額
$8.8B
CARSGEN-Bとは何ですか？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.